Two Questions, Zero Prep: What We’d Ask Each Other (If We Were the Guests)

The Life Science Insider is back with a brand-new video-first format — and this kickoff episode gets real fast.

In this raw, unscripted premiere, Seuss+ Co-Founders and Co-CEOs Kieran Canisius and Sabine Hutchison flip the script and interview each other—no prep, no pitch, just real talk about what’s quietly breaking biotech programs.

With decades in the biotech trenches, they expose the often-overlooked missteps in vendor selection, investor dynamics, and clinical execution that derail even the most promising studies.

You’ll hear:

• What vendors are still getting wrong in bid defense
• How “First Patient In” pressures can distort decisions
• Why poor vendor selection quietly unravels biotech success
• What needs to change—and what success actually looks like

💬 This episode is for biotech leaders, VCs, clinical ops professionals, and anyone tired of the trial-and-error approach to trial execution.

🔗 Learn more about Seuss+: https://www.seuss.plus